Longevity Health Holdings Inc. (XAGE) Revenue History
Annual and quarterly revenue from 2021 to present
XAGE Revenue Over Time (2021–2024)
XAGE Revenue Growth History
- FY2021 revenue growth
- N/A
- FY2022 revenue growth
- N/A
- FY2023 revenue growth
- N/A
- FY2024 revenue growth
- N/A
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2025 | $426K | +1975.5% |
| Q2 2025 | $504K | +3987.8% |
| Q1 2025 | $510K | — |
| Q4 2024 | $17K | +100.5% |
| Q3 2024 | $21K | -99.4% |
| Q2 2024 | $12K | — |
| Q1 2024 | $0 | — |
| Q4 2023 | $-3,728,816 | — |
Multi-year avg. share of annual revenue by fiscal quarter
XAGE Revenue Analysis (2021–2024)
Current Revenue & Growth
As of June 23, 2026, Longevity Health Holdings Inc. (XAGE) generated trailing twelve-month (TTM) revenue of $1.5 million, reflecting explosive growth of +1975.5% year-over-year. The most recent quarter (Q3 2025) recorded $425,864 in revenue, down 15.4% sequentially.
Historical Growth Trajectory
XAGE's historical revenue data shows various trends over time. Longevity Health Holdings Inc.'s highest annual revenue of $50,318 was recorded in 2024, an all-time high.
Peer Comparison
Compared to Healthcare sector peers — including HIMS (+32.8% YoY), MGRX (-18.9% YoY), and WELL (+38.3% YoY) — XAGE has outperformed the peer group in revenue growth. Compare XAGE vs HIMS →
XAGE Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| XAGECurrent | $1M | +1975.5% | - | -9933.8% | |
 HIMS | $2.3B | +32.8% | +73.6% | 4.5% | |
 MGRX | $456,021 | -18.9% | - | -4200.5% | |
 WELL | $10.7B | +38.3% | +18.4% | 3.3% | |
 GDRX | $797M | -1.2% | +7.7% | 11.0% | |
 TALK | $229M | +22.6% | +24.6% | 1.4% |
XAGE Historical Revenue Data (2021–2024)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | $50K | - | $44K | 87.4% | $-4,998,498 | -9933.8% |
| 2023 | $0 | - | $-124,788 | - | $-5,217,280 | - |
| 2022 | $0 | - | $-242,556 | - | $-5,507,641 | - |
| 2021 | $0 | - | $0 | - | $-467,431 | - |
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
5+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
XAGE — Frequently Asked Questions
Quick answers to the most common questions about buying XAGE stock.
Is XAGE's revenue growth accelerating or slowing?
XAGE revenue growth is accelerating. TTM revenue reached $1M, up +1975.5% year-over-year — ahead of the 5-year CAGR of N/A. This indicates the business is expanding faster than its historical baseline.
What is XAGE's revenue history from 2021 to 2026?
Longevity Health Holdings Inc. (XAGE) revenue history spans 2021 to 2026. TTM revenue as of 2026 is $1M, growing at +1975.5% YoY. The 5-year CAGR is N/A. Complete annual and quarterly revenue figures are available on this page, including gross profit, operating income, and margin trends.
What is XAGE's long-term revenue growth rate (CAGR)?
Longevity Health Holdings Inc.'s 5-year revenue CAGR of N/A reflects the sustained nature of its business expansion. As of 2026, the current YoY growth rate of +1975.5% is above this long-term average. CAGR is the most reliable measure of sustained revenue momentum for XAGE.
Why does XAGE's quarterly revenue fluctuate?
XAGE quarterly revenue can fluctuate significantly between periods. A quarter-over-quarter (QoQ) change does not always indicate a trend; comparing the same quarter year-over-year (YoY) is a more reliable signal for underlying growth. Longevity Health Holdings Inc.'s revenue data from 2021 to 2026 shows full historical quarterly detail on this page.
How is XAGE's revenue distributed by segment?
XAGE reports revenue broken down by product line and geographic region. The segment breakdown on this page shows which business units contribute the most to total revenue as of the latest fiscal year. Concentration in a single segment above 50% indicates category dependence, while a diversified mix signals more resilient revenue streams.
How does XAGE's revenue compare to industry peers?
Longevity Health Holdings Inc. (XAGE) with TTM revenue of $1M and +1975.5% YoY growth can be benchmarked against sector peers using the comparison table on this page. Revenue growth relative to peers indicates market share gains or losses. The peer section shows TTM revenue, YoY growth, and operating margin for direct comparisons.